{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:45:35Z","timestamp":1793357135417,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"am","delay-in-days":202,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018662","name":"Mitsukoshi Health and Welfare Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H06236"],"award-info":[{"award-number":["16H06236"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H03573"],"award-info":[{"award-number":["20H03573"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013236","name":"MSD Life Science Foundation, Public Interest Incorporated Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013236","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.trsl.2023.02.004","type":"journal-article","created":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T23:24:46Z","timestamp":1676849086000},"page":"16-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Apolipoprotein M\/sphingosine 1-phosphate protects against diabetic nephropathy"],"prefix":"10.1016","volume":"258","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-1145","authenticated-orcid":false,"given":"Makoto","family":"Kurano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomo","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2023.02.004_bib0001","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jdi.13355","article-title":"Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: estimates from Global Burden of Disease 2017","volume":"12","author":"Li","year":"2021","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.trsl.2023.02.004_bib0002","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Group","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2023.02.004_bib0003","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1096\/fj.201801748R","article-title":"Apolipoprotein M suppresses the phenotypes of IgA nephropathy in hyper-IgA mice","volume":"33","author":"Kurano","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2023.02.004_bib0004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1681\/ASN.2020050697","article-title":"Sphingosine-1-phosphate metabolism and signaling in kidney diseases","volume":"32","author":"Drexler","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2023.02.004_bib0005","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1681\/ASN.2013121351","article-title":"Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury","volume":"26","author":"Bajwa","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2023.02.004_bib0006","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/ki.2011.281","article-title":"Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation","volume":"80","author":"Park","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2023.02.004_bib0007","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1681\/ASN.2011050503","article-title":"Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury","volume":"23","author":"Park","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2023.02.004_bib0008","article-title":"The apoM\/S1P complex-A mediator in kidney biology and disease?","volume":"8","author":"Bisgaard","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.trsl.2023.02.004_bib0009","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","article-title":"Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M","volume":"108","author":"Christoffersen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2023.02.004_bib0010","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.bbalip.2014.05.002","article-title":"Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate","volume":"1841","author":"Kurano","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2023.02.004_bib0011","doi-asserted-by":"crossref","first-page":"ra79","DOI":"10.1126\/scisignal.aaa2581","article-title":"HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation","volume":"8","author":"Galvani","year":"2015","journal-title":"Sci Signal"},{"key":"10.1016\/j.trsl.2023.02.004_bib0012","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nature14462","article-title":"HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation","volume":"523","author":"Blaho","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2023.02.004_bib0013","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5551\/jat.RV17010","article-title":"Sphingosine 1-phosphate and atherosclerosis","volume":"25","author":"Kurano","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.trsl.2023.02.004_bib0014","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2337\/dc16-1246","article-title":"Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: the AMD annals initiative","volume":"39","author":"Russo","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2023.02.004_bib0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archinternmed.2009.471","article-title":"Prevention of diabetic nephropathy by tight target control in an Asian population with type 2 diabetes mellitus: a 4-year prospective analysis","volume":"170","author":"Tu","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.trsl.2023.02.004_bib0016","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/ndt\/gfr417","article-title":"Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients","volume":"27","author":"Hanai","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2023.02.004_bib0017","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/db19-0811","article-title":"Protection against insulin resistance by Apolipoprotein M\/Sphingosine-1-Phosphate","volume":"69","author":"Kurano","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2023.02.004_bib0018","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/ki.2010.544","article-title":"Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes","volume":"79","author":"Awad","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2023.02.004_bib0019","doi-asserted-by":"crossref","first-page":"e12866","DOI":"10.1111\/eci.12866","article-title":"High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate","volume":"48","author":"Brinck","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.trsl.2023.02.004_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12944-017-0556-9","article-title":"Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome","volume":"16","author":"He","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.trsl.2023.02.004_bib0021","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.atherosclerosis.2018.06.815","article-title":"Apolipoprotein M in patients with chronic kidney disease","volume":"275","author":"Sorensen","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.trsl.2023.02.004_bib0022","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.clinbiochem.2015.08.001","article-title":"The effect of nephropathy on plasma sphingosine 1-phosphate concentrations in patients with type 2 diabetes","volume":"48","author":"Bekpinar","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.trsl.2023.02.004_bib0023","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2337\/db21-0920","article-title":"Plasma ApoM levels and progression to kidney dysfunction in type 1 diabetics","volume":"71","author":"Baker","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2023.02.004_bib0024","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jdi.12319","article-title":"A new Classification of diabetic nephropathy 2014: a report from Joint Committee on diabetic nephropathy","volume":"6","author":"Haneda","year":"2015","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.trsl.2023.02.004_bib0025","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1055\/s-0038-1641750","article-title":"Apolipoprotein M protects lipopolysaccharide-treated mice from death and organ injury","volume":"118","author":"Kurano","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2023.02.004_bib0026","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2013.04.024","article-title":"Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M","volume":"229","author":"Kurano","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.trsl.2023.02.004_bib0027","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/ATVBAHA.116.308692","article-title":"Involvement of CETP (cholesteryl ester transfer protein) in the shift of sphingosine-1-phosphate among lipoproteins and in the modulation of its functions","volume":"37","author":"Kurano","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2023.02.004_bib0028","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/jalm\/jfaa022","article-title":"Establishment of a measurement system for sphingolipids in the cerebrospinal fluid based on liquid chromatography-tandem mass spectrometry, and its application in the diagnosis of carcinomatous meningitis","volume":"5","author":"Sakai","year":"2020","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.trsl.2023.02.004_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219403","article-title":"Use of gas chromatography mass spectrometry to elucidate metabolites predicting the phenotypes of IgA nephropathy in hyper IgA mice","volume":"14","author":"Kurano","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2023.02.004_bib0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1523-1755.2004.00711.x","article-title":"Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines","volume":"66","author":"Schiwek","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2023.02.004_bib0031","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1074\/jbc.M114.596445","article-title":"LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate","volume":"290","author":"Kurano","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2023.02.004_bib0032","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1021\/bi9515533","article-title":"N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets","volume":"35","author":"Yatomi","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.trsl.2023.02.004_bib0033","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jb\/mvi100","article-title":"Sphingosine 1-phosphate-related metabolism in the blood vessel","volume":"138","author":"Aoki","year":"2005","journal-title":"J Biochem"},{"key":"10.1016\/j.trsl.2023.02.004_bib0034","doi-asserted-by":"crossref","first-page":"14655","DOI":"10.1096\/fj.202001397R","article-title":"Modulation of sphingosine 1-phosphate by hepatobiliary cholesterol handling","volume":"34","author":"Kurano","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2023.02.004_bib0035","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1038\/nprot.2006.351","article-title":"Analysis of mitochondrial function using phosphorescent oxygen-sensitive probes","volume":"1","author":"Will","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.trsl.2023.02.004_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149462","article-title":"Increased mRNA levels of sphingosine kinases and S1P lyase and reduced levels of S1P were observed in hepatocellular carcinoma in association with poorer differentiation and earlier recurrence","volume":"11","author":"Uranbileg","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2023.02.004_bib0037","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cca.2019.07.005","article-title":"Mitochondrial dysfunction in diabetic kidney disease","volume":"496","author":"Wei","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.trsl.2023.02.004_bib0038","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1074\/jbc.M609648200","article-title":"Identification of the hydrophobic ligand binding pocket of the S1P1 receptor","volume":"282","author":"Fujiwara","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2023.02.004_bib0039","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1126\/science.1215904","article-title":"Crystal structure of a lipid G protein-coupled receptor","volume":"335","author":"Hanson","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.trsl.2023.02.004_bib0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tips.2013.05.002","article-title":"The structure and function of the S1P1 receptor","volume":"34","author":"O'Sullivan","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.trsl.2023.02.004_bib0041","doi-asserted-by":"crossref","first-page":"31286","DOI":"10.1074\/jbc.274.44.31286","article-title":"A novel human apolipoprotein (apoM)","volume":"274","author":"Xu","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2023.02.004_bib0042","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1078\/0065-1281-00687","article-title":"Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization","volume":"105","author":"Zhang","year":"2003","journal-title":"Acta Histochem"},{"key":"10.1016\/j.trsl.2023.02.004_bib0043","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3701385","article-title":"FTY720 attenuates angiotensin II-induced podocyte damage via inhibiting inflammatory cytokines","volume":"2017","author":"Su","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.trsl.2023.02.004_bib0044","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/jdi.12232","article-title":"Modulation of sphingosine-1-phosphate and apolipoprotein M levels in the plasma, liver and kidneys in streptozotocin-induced diabetic mice","volume":"5","author":"Nojiri","year":"2014","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.trsl.2023.02.004_bib0045","doi-asserted-by":"crossref","first-page":"730","DOI":"10.5551\/jat.55699","article-title":"Glycation of HDL polymerizes apolipoprotein M and attenuates its capacity to bind to sphingosine 1-phosphate","volume":"28","author":"Kobayashi","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.trsl.2023.02.004_bib0046","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12944-016-0246-z","article-title":"HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications","volume":"15","author":"Li","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.trsl.2023.02.004_bib0047","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9416419","article-title":"Animal models of diabetes-associated renal injury","volume":"2020","author":"Noshahr","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.trsl.2023.02.004_bib0048","article-title":"LC-MS-based untargeted metabolomics reveals early biomarkers in STZ-induced diabetic rats with cognitive impairment","volume":"12","author":"Chen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.trsl.2023.02.004_bib0049","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1165\/rcmb.2020-0408OC","article-title":"Endothelial-specific loss of sphingosine-1-phosphate receptor 1 increases vascular permeability and exacerbates bleomycin-induced pulmonary fibrosis","volume":"66","author":"Knipe","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.trsl.2023.02.004_bib0050","doi-asserted-by":"crossref","first-page":"e87058","DOI":"10.1172\/jci.insight.87058","article-title":"HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver","volume":"1","author":"Ding","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2023.02.004_bib0051","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.devcel.2020.05.024","article-title":"Aging suppresses sphingosine-1-phosphate chaperone ApoM in circulation resulting in maladaptive organ repair","volume":"53","author":"Ding","year":"2020","journal-title":"Dev Cell"},{"key":"10.1016\/j.trsl.2023.02.004_bib0052","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1096\/fj.201500064","article-title":"Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1","volume":"30","author":"Christensen","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2023.02.004_bib0053","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/ATVBAHA.116.308435","article-title":"High-density lipoprotein-associated apolipoprotein m limits endothelial inflammation by delivering sphingosine-1-phosphate to the sphingosine-1-phosphate receptor 1","volume":"37","author":"Ruiz","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2023.02.004_bib0054","doi-asserted-by":"crossref","first-page":"e52690","DOI":"10.7554\/eLife.52690","article-title":"Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta","volume":"9","author":"Engelbrecht","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.trsl.2023.02.004_bib0055","article-title":"Circulating cord blood HDL-S1P complex preserves the integrity of the feto-placental vasculature","volume":"1865","author":"Del Gaudio","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.trsl.2023.02.004_bib0056","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021261","article-title":"Endothelial Spns2 and ApoM regulation of vascular tone and hypertension via sphingosine-1-phosphate","volume":"10","author":"Del Gaudio","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.trsl.2023.02.004_bib0057","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/hep.25780","article-title":"Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents","volume":"56","author":"Kageyama","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2023.02.004_bib0058","doi-asserted-by":"crossref","first-page":"14557","DOI":"10.1021\/acs.jmedchem.1c01066","article-title":"Discovery and optimization of orally bioavailable phthalazone and cinnolone carboxylic acid derivatives as S1P2 antagonists against fibrotic diseases","volume":"64","author":"Mammoliti","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.trsl.2023.02.004_bib0059","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/bjophthalmol-2021-319115","article-title":"Sphingosine 1-phosphate, a potential target in neovascular retinal disease","volume":"106","author":"Alshaikh","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.trsl.2023.02.004_bib0060","doi-asserted-by":"crossref","first-page":"630","DOI":"10.5551\/jat.54916","article-title":"Inhibition of S1P Receptor 2 attenuates endothelial dysfunction and inhibits atherogenesis in Apolipoprotein E-deficient mice","volume":"28","author":"Ganbaatar","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.trsl.2023.02.004_bib0061","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1010268","article-title":"Mitochondrial dysfunction and diabetic nephropathy: nontraditional therapeutic opportunities","volume":"2021","author":"Zhang","year":"2021","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.trsl.2023.02.004_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106014","article-title":"SIRT1-FOXOs activity regulates diabetic complications","volume":"175","author":"Jalgaonkar","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.trsl.2023.02.004_bib0063","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/bph.13360","article-title":"Resveratrol exerts a biphasic effect on apolipoprotein M","volume":"173","author":"Kurano","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trsl.2023.02.004_bib0064","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.1176709","article-title":"Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate","volume":"325","author":"Hait","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.trsl.2023.02.004_bib0065","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1210\/me.2005-0209","article-title":"Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M","volume":"20","author":"Faber","year":"2006","journal-title":"Mol Endocrinol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524423000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524423000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:47:04Z","timestamp":1761828424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524423000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":65,"alternative-id":["S1931524423000245"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2023.02.004","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein M\/sphingosine 1-phosphate protects against diabetic nephropathy","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2023.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}